Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders by Sung Sik Choe et al.
April 2016 | Volume 7 | Article 301
Review
published: 13 April 2016
doi: 10.3389/fendo.2016.00030
Frontiers in Endocrinology | www.frontiersin.org
Edited by: 
Gary Sweeney, 
York University, Canada
Reviewed by: 
Carol Huang, 
University of Calgary, Canada 
Daniel Konrad, 
University Children’s Hospital Zurich, 
Switzerland
*Correspondence:
Jae Bum Kim  
jaebkim@snu.ac.kr
Specialty section: 
This article was submitted to 
Cellular Endocrinology, 
a section of the journal 
Frontiers in Endocrinology
Received: 21 November 2015
Accepted: 31 March 2016
Published: 13 April 2016
Citation: 
Choe SS, Huh JY, Hwang IJ, Kim JI 
and Kim JB (2016) Adipose Tissue 
Remodeling: Its Role in Energy 
Metabolism and Metabolic Disorders. 
Front. Endocrinol. 7:30. 
doi: 10.3389/fendo.2016.00030
Adipose Tissue Remodeling:  
its Role in energy Metabolism and 
Metabolic Disorders
Sung Sik Choe , Jin Young Huh , In Jae Hwang , Jong In Kim and Jae Bum Kim*
Department of Biological Sciences, National Creative Research Initiatives Center for Adipose Tissue Remodeling, Institute of 
Molecular Biology and Genetics, Seoul National University, Seoul, South Korea
The adipose tissue is a central metabolic organ in the regulation of whole-body energy 
homeostasis. The white adipose tissue functions as a key energy reservoir for other 
organs, whereas the brown adipose tissue accumulates lipids for cold-induced adaptive 
thermogenesis. Adipose tissues secrete various hormones, cytokines, and metabolites 
(termed as adipokines) that control systemic energy balance by regulating appetitive 
signals from the central nerve system as well as metabolic activity in peripheral tissues. 
In response to changes in the nutritional status, the adipose tissue undergoes dynamic 
remodeling, including quantitative and qualitative alterations in adipose tissue-resident 
cells. A growing body of evidence indicates that adipose tissue remodeling in obesity 
is closely associated with adipose tissue function. Changes in the number and size 
of the adipocytes affect the microenvironment of expanded fat tissues, accompanied 
by alterations in adipokine secretion, adipocyte death, local hypoxia, and fatty acid 
fluxes. Concurrently, stromal vascular cells in the adipose tissue, including immune 
cells, are involved in numerous adaptive processes, such as dead adipocyte clearance, 
adipogenesis, and angiogenesis, all of which are dysregulated in obese adipose tissue 
remodeling. Chronic overnutrition triggers uncontrolled inflammatory responses, leading 
to systemic low-grade inflammation and metabolic disorders, such as insulin resistance. 
This review will discuss current mechanistic understandings of adipose tissue remodel-
ing processes in adaptive energy homeostasis and pathological remodeling of adipose 
tissue in connection with immune response.
Keywords: adipose tissue, adipose tissue macrophage, hypertrophic adipocyte, inflammatory response, iNKT 
cell, metabolic disorder, obesity
iNTRODUCTiON
The adipose tissue is a critical regulator of systemic energy homeostasis by acting as a caloric reservoir. 
In excess nutrient conditions, the adipose tissue stores surplus nutrients in the form of neutral lipids, 
whereas in nutrient deficit conditions, it supplies nutrients to other tissues through lipolysis (1). In 
the past several decades, overnutrition and reduced daily activity have greatly increased obesity rates 
worldwide, creating a global health emergency due to concomitant increases in insulin resistance, 
type 2 diabetes, heart disease, atherosclerosis, hypertension, and many types of cancer (2–4). In 
response to alterations in the energy status, the adipose tissue is rapidly and dynamically remodeled 
through changes in the number and/or size of adipocytes. Simultaneously, various stromal vascular 
FiGURe 1 | Adipose tissue functions in energy homeostasis and thermal regulation. (A) In humans, BAT localized around the shoulders and ribs contributes 
to heat generation. Brown adipocytes exhibit abundant mitochondria and UCP-1 expression related to thermogenesis. It has recently been speculated that BAT 
efficiency for fat-burning could be harnessed to reduce obesity. Visceral WAT (VAT) and subcutaneous WAT (SAT) possesses considerable capacities for energy 
storage. VAT surrounds intra-abdominal organs, whereas SAT spreads throughout the body beneath the skin. These fat tissues secrete various adipokines to 
regulate energy homeostasis. VAT is more strongly associated with obesity-induced metabolic disorders than SAT. (B) In adult mice, BAT is well developed and 
easily observed compared with that in adult humans. Among WAT depots within the abdominal cavity, the paired gonadal depots located around the ovaries in 
females and the testes in males are studied as a model of VAT. However, these depots do not exist in humans. The paired inguinal depots in the anterior to the 
upper part of the hind limbs are representative SATs in mice.
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cells in the adipose tissue undergo numerical and/or functional 
changes, contributing to the maintenance of the adipose tis-
sue function as an energy reservoir and endocrine organ. This 
series of events is called “adipose tissue remodeling.” However, 
under pathophysiological conditions, such as obesity, aberrant 
adipose tissue remodeling may induce dysregulation of adipose 
tissue-derived cytokines, hormones, and metabolites, leading to 
metabolic stresses and disorders in metabolic organs (2–4).
FUNCTiONAL COMPLeXiTY OF THe 
ADiPOSe TiSSUe
The Adipose Tissue as a Specialized 
energy Storage Organ
Living organisms need to consume energy from their environ-
ments to survive. In particular, storage of extra energy obtained 
during food abundance is an essential physiological activity that 
enhances survival during food scarcity periods. Multicellular 
organisms have evolved specialized cells or organs to store excess 
nutrients as lipids because lipids have higher calories than other 
nutrients. For example, Caenorhabditis elegans stores surplus 
energy in the form of lipids in intestinal cells (5), whereas sharks 
and Drosophila accumulate excess lipids in the liver and fat 
body, respectively (6, 7). In other organisms, particularly some 
fishes and higher vertebrates, the adipose tissue functions as a 
specialized energy reservoir (1). The adipose tissue is distributed 
throughout the body and is capable of expanding to accommodate 
excess energy in the form of accumulated lipids, characteristics 
distinguishing the adipose tissue from other organs and tissues 
(8). In humans, there are two major types of adipose tissues, 
white adipose tissue (WAT) and brown adipose tissue (BAT). 
Anatomically, WAT comprises two major depots, subcutaneous 
WAT (SAT) and visceral WAT (VAT) around internal organs. 
VAT, which is concentrated in the abdominal cavity, is further 
subdivided into mesenteric, omental, perirenal, and peritoneal 
depots (Figure  1) (8, 9). The key physiological functions of 
WAT are insulation and energy storage. In obesity, however, 
excess VAT is closely linked to metabolic complications, such 
as insulin resistance and type 2 diabetes (8, 9). Mesenteric and 
omental adipose tissues are particularly important for hepatic 
insulin resistance and steatosis because liver is directly exposed 
to releasing factors from these adipose tissues via the portal vein. 
As an animal model, rodents have gonadal adipose tissue that 
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is considered part of VAT. However, because of lack of gonadal 
adipose tissue in humans, careful interpretation is required to 
extrapolate findings in rodents to human. BAT is a specialized 
form that participates in non-shivering thermogenesis through 
lipid oxidation (10, 11). The distinct brown color of BAT is attrib-
uted to its high mitochondrial density, which is critical for heat 
generation and lipid oxidation (10, 11). Although BAT is readily 
observed in both infant and adult rodents, it has been proposed 
that BAT in humans is limited to neonates and is gradually 
replaced by WAT with aging. However, recent positron emission 
tomography/computed tomography studies have shown that BAT 
is viable and functional in human adults (12, 13). Thus, various 
adipose tissues act as central regulators of energy homeostasis 
by storing excess energy as well as by controlling thermogenesis.
The Adipose Tissue as an endocrine 
Organ Regulating energy Homeostasis
The adipose tissue has been historically considered merely an 
energy storage depot, but this concept was revised following 
the discovery of leptin, the first adipocyte-derived cytokine, by 
Friedman’s group in 1990. Leptin release in response to changes 
in nutritional status indicates that the adipose tissue acts as an 
endocrine organ involved in modulating energy homeostasis 
(14, 15). Since this discovery, additional cytokines, hormones, 
and peptides secreted by adipocytes, collectively termed as 
“adipokines,” have been identified and intensively investigated 
for roles in the control of energy homeostasis (16). Leptin, one of 
the most well studied adipokines, is secreted in response to food 
intake and inhibits appetite by regulating neural circuits located 
in the brain. Leptin acts on surface receptors expressed in AGRP 
neurons in the lateral hypothalamus and POMC neurons in the 
medial hypothalamus to inhibit appetite and stimulate satiety, 
respectively (17–19). Mice homozygous for the leptin mutation 
ob/ob or leptin receptor mutation db/db are massively obese 
because of uncontrolled appetite and ensuing excess food intake 
(20, 21). Leptin also promotes lipid oxidation and mitochondrial 
biogenesis and accelerates energy expenditure in peripheral tis-
sues through both local signaling and regulation of brain-derived 
factors (22, 23). Circulating leptin is actually elevated in obesity, 
but hypothalamic leptin resistance aggravates obesity through 
inhibition of appetite control and lipid oxidation (17–19).
Adiponectin is another adipocyte-secreted adipokine that 
is abundant in the blood (24–26). Adiponectin exerts anti-
obesity and antidiabetic effects and alleviates insulin resistance 
by stimulating lipid oxidation and anti-inflammatory responses 
(27–32). There are two major receptors for adiponectin AdipoR1 
and AdipoR2. Both receptors stimulate AMP-activated protein 
kinase (AMPK), which is necessary for the anti-obesity and anti-
diabetic actions of adiponectin (29–31). There are two distinct 
forms of circulating plasma adiponectin, a low molecular weight 
(LMW) full-length trimer and a hexamer. The full-length trimer 
aggregates via disulfide bonding into high molecular weight 
(HMW) multimers of 12–18 monomers. It has been reported that 
these multimers are the primary bioactive forms and that each 
may exert different biological effects. In obesity, the circulating 
plasma levels of HMW and LMW adiponectin are reduced, and 
this altered adiponectin oligomeric profile has been suggested to 
be a reliable clinical indicator of metabolic disorders (33).
Recent studies have identified additional adipokines that pro-
mote obesity and associated morbidities (34–37). For instance, 
resistin, an adipokine mainly secreted from VAT, is elevated in 
obesity. In mice, administration of resistin impairs glucose toler-
ance and insulin action, implying that elevated levels of resistin 
may link obesity to diabetes (34). Given that the resistin receptor 
has not been identified, the molecular pathways through which 
resistin induces insulin resistance in obesity are still uncertain. 
Retinol-binding protein 4, another adipokine upregulated in 
serum of insulin-resistance mice and humans, impairs insulin 
signaling in liver and muscle (35). In contrast, omentin, identi-
fied in the human omental adipose depot, regulates blood glucose 
level by enhancing insulin action and is decreased in obesity (36, 
37). The recently identified adipokine nesfatin, primarily derived 
from SAT, modulates appetite according to the nutrient status 
(38). In addition to peptide adipokines, lipid metabolites called 
“lipokines” have also been discovered. In the adipose tissue, 
C16:1n7-palmitoleate is synthesized de novo via stearoyl-CoA 
desaturase-1. Secreted C16:1n7-palmitoleate improves muscle 
insulin sensitivity and suppresses fat accumulation in the liver 
(hepatosteatosis) (39). The identification of multiple adipokines 
and lipokines with disparate cellular actions underscores the 
central role of adipose tissue depots as endocrine organs in the 
dynamic regulation of systemic energy homeostasis.
The Adipose Tissue as a  
Thermal Regulator
Compared with WAT, BAT is characterized by multilocular 
lipid droplets, rich vascularization, and abundant mitochondria. 
Unlike WAT, BAT functions prominently in thermoregulation 
through lipid oxidation-mediated heat generation (10, 11). 
Although both BAT and muscles harbor high levels of mitochon-
dria, BAT is specialized for heat generation rather than for ATP 
synthesis by high expression of mitochondrial uncoupling pro-
tein 1 (UCP-1) (10, 11). The adipose tissues express high levels of 
β-adrenergic receptors that mediate cold-induced lipolysis (40). 
After cold exposure, it appears that large amounts of lipids from 
WAT flow into BAT (40). Concurrently, β-adrenergic signaling 
in BAT activates the expression of peroxisome proliferator-
activated receptor γ coactivator 1α (PGC-1α), which stimulates 
the expression of UCP-1 and mitochondrial genes (41). In 
addition to UCP-1 expression, cold-induced BAT enhances 
lipid uptake for the efficient production of heat, accompanied by 
mitochondrial biogenesis (40). In accordance with this general 
model of homeostatic thermogenesis, it has been reported that 
cold exposure elevates the expression of pro-angiogenic fac-
tors, including vascular endothelial growth factor (VEGF), and 
impedes the expression of anti-angiogenic factors in BAT (42). 
VEGF receptor (VEGFR) 2 blockage abolishes cold-induced 
angiogenesis and impairs thermogenic capacity, indicating that 
angiogenic remodeling of BAT is one of important factors for 
thermoregulation (42).
Emerging evidence suggests that both BAT and SAT con-
tribute to thermal regulation (43). Cold exposure induces 
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“beiging” remodeling of SAT to the BAT phenotype (referred 
to as “adipose tissue browning”) (40, 43). Although beige/bright 
adipocytes and brown adipocytes share the ability for thermo-
genesis, there are several differences. First, myogenic factor 
five-negative beige adipocytes are derived from different devel-
opmental lineages compared with myogenic factor five-positive 
brown adipocytes (44). Second, even though PRD1-BF-RIZ1 
homologous domain-containing protein-16 (PRDM16) has 
been recognized as a critical transcriptional coactivator for both 
brown and beige adipocytes, PRDM16 depletion impedes beige 
adipocyte development upon β-adrenergic stimulation but has 
no effect on brown adipocyte development or function (45, 46). 
To date, two hypotheses have been proposed for beige adipo-
cyte differentiation: one is that beige adipocytes are derived by 
transdifferentiation of mature white adipocytes and the other is 
that beige adipocytes are differentiated from specific precursors 
(47–51). Permanent or inducible labeling of adipocyte lineages 
in mice demonstrated that the increased number of subcutane-
ous beige adipocytes after cold exposure resulted from de novo 
adipogenesis (51), indicating that there are distinct precursor 
cells capable of differentiating into beige adipocytes in SAT. 
It has also been reported that temperature can reverse this 
transformation in SAT. Beige adipocytes formed by cold stimu-
lation revert to typical white adipocytes after warm adaptation 
(50). Moreover, subsequent cold stimulation reconverts these 
white-typical adipocytes to beige adipocytes. These results 
suggest the potential for repeated transdifferentiation of white 
adipocytes into beige adipocytes. Although it remains contro-
versial whether mouse beige adipocytes have an equivalent 
cell population in human SAT, it has been demonstrated that 
human adult BAT consists of both classical brown adipocytes 
and beige adipocytes (52, 53). Moreover, recent marker gene 
analyses have suggested that the supraclavicular BAT of adult 
humans appears to consist of beige adipocytes rather than clas-
sical brown adipocytes (52–55).
Several cytokines are involved in the stimulation of beiging 
and/or browning. For instance, fibroblast growth factor 21 
(FGF21) activates PGC-1α and accelerates the function of brown 
adipocytes (56–58). The newly identified adipokine irisin has 
been reported to link muscle-induced shivering thermogenesis 
to FGF21-induced brown (beige) adipose tissue-mediated non-
shivering thermogenesis (59). Bone morphogenetic proteins 
(BMPs) 4 and 7 are also associated with the browning of adi-
pocytes (60, 61). A better understanding of BAT activation and 
WAT browning may lead to the discovery of valuable therapeutic 
targets for the treatment of obesity and metabolic diseases (40, 43, 
62). Despite these findings, more studies are needed to elucidate 
the molecular mechanisms of beiging/browning of adipocytes as 
well as their developmental origins.
HYPeRTROPHiC AND HYPeRPLASiC 
ADiPOSe TiSSUe eXPANSiON
Two Modes of Adipose Tissue expansion
Adipose tissue expansion in obesity could be mediated by 
hypertrophy (enlarged adipocytes), hyperplasia (increased 
numbers of adipocytes), or both (Figure 2). Adipocyte hyper-
trophy and hyperplasia are regulated by environmental and 
genetic factors (63). However, it is still uncertain how these 
two modes of adipose tissue expansion are controlled at the 
molecular level. In humans, SAT develops during weeks 14–24 
of fetal gestation from the head and neck to the trunk and limbs 
through an increase in the number of adipocytes. By 28 weeks, 
major fat depots are organized (64). During the first year after 
birth, both adipocyte number and size increase in humans. 
The number of adipocytes then appears to remain stable until 
adolescence, when it increases once again (65, 66). In contrast to 
SAT development, very little is known about the developmental 
period of VAT. It has been shown that VAT is rarely formed 
before birth and that the total amount of VAT remains small 
until adolescence (67, 68).
Both SAT and VAT masses are markedly increased in obese 
humans. In childhood obesity, WAT mass expansion is accompa-
nied by adipocyte hyperplasia (69, 70). In obese animal models, 
it has been proposed that de novo adipogenesis begins when 
the adipocytes reach an upper volume limit (51, 71). Thereafter, 
formation of new adipocytes from precursor cells is required for 
further increases in energy storage capacity. In adult humans, 
however, the increase in WAT mass that triggers metabolic disor-
ders is primarily due to adipocyte hypertrophy (72, 73). Spalding 
et  al. reported that adipocyte numbers are roughly constant in 
lean and obese adults (74). In addition, neither the number nor 
the turnover rate of adipocytes during adulthood is altered by 
obesity or weight loss, implying that adipocyte hypertrophy is the 
predominant contributor to adult obesity.
Hypertrophic Adipocytes
In recent decades, many studies have suggested that adipocyte 
hypertrophy per  se results in abnormal adipocyte function 
and leads to insulin resistance (75–79). The distinguishing 
features of hypertrophic adipocytes are as follows. First, in the 
obese adipose tissue, hypertrophic adipocytes show necrotic-
like abnormalities (80–82). Necrosis-like adipocyte death is 
increased in hormone-sensitive lipase-deficient mice with 
adipocyte hypertrophy as well as in diet-induced obesity (DIO) 
mouse models (80–82). It has been proposed that an increase in 
dead adipocytes in obesity will impede adipose tissue function 
and induce inflammation. Second, hypertrophic adipocytes 
exhibit increased expression and secretion of pro-inflammatory 
cytokines, including tumor necrosis factor α (TNFα), inter-
leukin (IL)-6, IL-8, and monocyte chemoattractant protein-1 
(MCP-1) (83). This elevation of pro-inflammatory cytokines 
leads to serine phosphorylation of insulin receptor substrate-1 
via nuclear factor κB and Jun N-terminal kinase signaling, 
resulting in the development of insulin resistance (84, 85). Pro-
inflammatory cytokines also promote adipose tissue inflamma-
tion by recruiting various immune cells, including macrophages 
and T cells (2–4). Third, adipocyte hypertrophy induces local 
adipose tissue hypoxia because of a relative deficiency of vas-
culature (86–88). When hypoxia occurs in the adipose tissue, 
the expression levels of angiogenic factors and inflammatory 
response-associated genes are upregulated (86, 88, 89). Activation 
of hypoxia- inducible factor (HIF) 1α, a key transcription factor 
FiGURe 2 | Characteristics of hypertrophic and hyperplasic adipocytes. In obesity, adipose tissue expansion occurs by two different mechanisms. 
Hypertrophic adipose expansion through increased adipocyte size is associated with such harmful phenomena as increased basal fatty acids release, pro-
inflammatory cytokine release, immune cell recruitment, hypoxia, fibrosis, decreased adiponectin, and impaired insulin sensitivity. On the other hand, hyperplasic 
adipose expansion though increased adipocyte number is linked to beneficial phenomena, such as increased adiponectin, decreased basal fatty acids release, 
pro-inflammatory cytokine release, immune cell recruitment, hypoxia, fibrosis, and improved insulin sensitivity.
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mediating hypoxic responses, accelerates adipose tissue fibrosis. 
Also, HIF1α  augments the local inflammatory response in the 
obese adipose tissue, whereas HIF2α attenuates adipose tissue 
inflammation in obesity (87, 90, 91). Moreover, basal lipolysis 
is elevated in hypertrophic adipocytes (92, 93), increasing the 
leakage of free fatty acids (FFAs). Large amounts of FFAs released 
from the obese adipose tissue are taken up by other tissues, such 
as the liver and muscle, which can cause ectopic lipid accumula-
tion and lipotoxicity (94, 95). Furthermore, saturated fatty acids, 
such as palmitic or stearic acids, activate the Toll-like receptor 
4 signaling cascade, which plays an essential role in innate 
immunity, leading to chronic inflammation as well as insulin 
resistance (96–98). It was recently reported that adipocyte hyper-
trophy also impairs insulin-dependent glucose uptake because 
of a defect in GLUT4 trafficking (79). Upon chronic treatment 
with FFAs, 3T3-L1 adipocytes become enlarged with unilocular 
lipid droplets, mimicking in vivo hypertrophic adipocytes. These 
unilocular and hypertrophic adipocytes show disrupted corti-
cal actin structures and impaired insulin-dependent GLUT4 
trafficking to the plasma membrane (Figure 3). Thus, it is likely 
that adipocyte hypertrophy impairs adipocyte function though 
both inflammation-dependent and inflammation-independent 
mechanisms, thereby exacerbating insulin resistance and dis-
rupting energy metabolism.
Hyperplastic Adipocytes
Adipocyte hypertrophy occurs more readily in SAT than VAT 
until adolescence (65, 66, 71, 99). For hyperplasic expansion of 
the adipose tissue, adipocyte precursor cells must differentiate 
into adipocytes, a process regulated by various transcription 
factors and hormones. Peroxisome proliferator-activated recep-
tor γ (PPARγ), a key regulator of adipogenesis, and CCAAT/
FiGURe 3 | Actin cytoskeleton and insulin-stimulated GLUT4 translocation control in adipocytes. In adipocytes, cytosolic and cortical actin organization is 
involved in GLUT4 storing vesicle (GSV) transport by insulin stimulation. When adipocytes are hypertrophied, enlarged unilocular lipid droplets and expanded cell 
volume may impede cortical actin dynamics, resulting in improper/deficient translocation of GSVs. This indicates the importance of the adipocyte cytoskeleton in the 
regulation of adipocyte glucose metabolism in response to insulin.
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enhancer binding protein families regulate the induction and 
maintenance of adipogenesis (100–102). Sterol regulatory ele-
ment-binding transcription factor 1c (SREBP1c) is another key 
transcription factor that stimulates the expression of lipogenic 
genes, including acetyl-CoA carboxylase, fatty acid synthase, 
and saturated fatty acid dehydrogenase. It has been reported 
that activation of SREBP1c provides endogenous PPARγ ligands 
and consequently increases adipogenesis (103, 104). Other 
extracellular signals, including BMPs, insulin-like growth fac-
tors, and WNT, modulate adipocyte differentiation (105–108). 
However, the molecular mechanisms of in vivo adipogenesis in 
normal and obese conditions remain elusive. Recently, several 
ex vivo and in vivo studies have identified adipocyte precursor 
cell types (109–113). In human WAT, adipocyte precursor cells 
are abundant among CD31− and CD34+ stromal vascular frac-
tions (109). In mice, more specific subpopulation of adipogenic 
precursor cells have been characterized, including highly pro-
adipogenic subpopulations of CD45–, CD31–, Ter119–, CD29+, 
CD34+, Sca-1+, and CD24+ cells (110). Subsequent studies have 
shown that these subpopulations can form fully functional WAT 
deposits when transplanted into A/Zip lipodystrophic mice, 
implying that these adipocyte precursor cells can proliferate 
and differentiate into adipocytes in  vivo. However, it remains 
unknown how and when adipocyte precursor cells can commit 
to adipocyte differentiation.
Many cohort studies have reported that several common 
parameters of obesity, including body mass index (BMI), insulin 
resistance, and cardiovascular diseases, are not always positively 
correlated with obesity. For instance, certain obese individuals 
with BMIs over 30 kg/m2 are insulin sensitive and exhibit normal 
metabolic parameters, including blood glucose and lipid levels, 
HOMA-IR, and plasma inflammatory markers. Such obese 
individuals are called “metabolically healthy obese” (MHO) (77, 
114–117). A frequent feature of the MHO population is a lower 
number of immune cells and a higher proportion of relatively 
small adipocytes in adipose tissues (77, 114, 115, 117). Moreover, 
there are several mouse models that show similar MHO pheno-
types (118, 119). Thiazolidinedione derivatives like rosiglitazone 
are antidiabetic agents that promote adipogenesis by acting as 
PPARγ ligands (120, 121). De novo small adipocytes are detected 
in obese db/db mice treated with rosiglitazone, and insulin-
dependent glucose uptake is enhanced in rosiglitazone-induced 
newly differentiated small adipocytes (79, 122). These findings 
suggest that de novo differentiation of small adipocyte could 
ameliorate insulin resistance in obesity by providing additional 
capacity to store excess energy. Although the implications of 
adipocyte hyperplasia in the adipose tissue function are not fully 
understood, the regulation of hyperplasic adipocytes may exert 
beneficial effects against adipocyte hypertrophy and subsequent 
insulin resistance.
FiGURe 4 | Balance of immune responses in the regulation of adipose tissue function. Lean adipose tissue harbors various anti-inflammatory immune cells, 
such as eosinophils, M2 macrophages, Th2 cells, iNKT cells, and Treg cells. These immune cells help in maintaining insulin sensitivity and store extra energy in the 
form of TGs. In obese adipose tissue, the numbers of pro-inflammatory immune cells, including neutrophils, M1 macrophages, mast cells, Th1 cells, and CD8  
T cells, are greatly elevated. Simultaneously reduced number of anti-inflammatory immune cells accelerates pro-inflammatory response and adipose tissue 
dysfunction.
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THe ADiPOSe TiSSUe iNFLAMMATiON 
AND MeTABOLiC COMPLiCATiONS
Obesity and Adipose Tissue inflammation
Inflammation is a biological defense response against harmful 
stimuli, such as pathogen invasion and cell damage (123). A close 
relationship between the inflammatory response and insulin 
resistance has been proposed on the basis of the suppression of 
insulin-dependent glucose uptake in sepsis patients (124, 125). 
Furthermore, the anti-inflammatory drug salicylate alleviates 
insulin resistance in diabetic subjects (126, 127). Expression of 
the inflammatory cytokine TNFα is increased in the obese adi-
pose tissue, whereas blockade of TNFα/TNFα receptor signaling 
by TNFα neutralization improves insulin-dependent glucose 
uptake (128). Other pro-inflammatory cytokines, such as IL-1β, 
IL-6, and MCP-1, are also upregulated in the obese adipose 
tissue (129). These results indicate that inflammatory cytokines 
secreted from the adipose tissue contribute to the induction of 
insulin resistance.
Immune cells residing in the adipose tissue actively secrete 
numerous pro- and anti-inflammatory cytokines (2–4). Anti-
inflammatory cytokines help in maintaining insulin sensitivity in 
the lean adipose tissue, while accumulation of pro-inflammatory 
cytokines in obesity leads to insulin resistance (2–4) (Figure 4). 
In addition, pro-inflammatory cytokines stimulate lipolysis 
in adipocytes, leading to lipotoxicity in other tissues (2, 3). In 
C57BL/6 mice, an inflammatory response was specifically induced 
in the adipose tissue but not in other metabolic tissues by a brief 
(1  week) high-fat diet (HFD) (130). During long-term HFD, 
however, pro-inflammatory responses were also greatly enhanced 
in other metabolic tissues, including the liver and muscles (130). 
This report proposes that inflammatory responses because of 
excess energy intake are primarily initiated in adipose tissues 
and that chronic inflammation of adipose tissues subsequently 
induces inflammation in other metabolic organs, such as the liver, 
muscle, and pancreas. Therefore, it is likely that inflammation is a 
causal factor for widespread systemic insulin resistance in obesity.
Pro-inflammatory Cytokine-Producing 
immune Cells
Adipose tissue remodeling is accompanied by reversible changes 
in immune cell composition as well as adipocyte size, altering 
numerous adipose tissue functions (2–4). The numbers of neutro-
phils and macrophages are rapidly increased in the adipose tissue 
upon HFD feeding (130–132). Neutrophils are the most abundant 
blood leukocyte type and rapidly react to inflammatory responses 
(133). It was reported that the expression levels of neutrophil-
derived elastase and myeloperoxidase (MPO) were elevated after 
only 3 days of HFD feeding in mice and that neutrophils quickly 
accumulated in the obese adipose tissue (131, 132). Both HFD-
induced adipose tissue inflammation and insulin resistance were 
attenuated in mice treated with a neutrophil elastase inhibitor and 
in neutrophil elastase knockout mice (132), implying that neutro-
phil elastase contributes to the pro-inflammatory response and 
insulin resistance in adipose tissues. However, one study reported 
that MPO-positive cells did not infiltration into adipose tissues 
of obese humans even though the levels of circulating MPO and 
neutrophils were elevated (134).
Macrophages are the most abundant cell type among adipose 
tissue leukocytes, constituting almost 50% of total immune 
cells (135, 136). The number of macrophages in adipose tissue 
prominently increases with obesity. Accumulated macrophages 
are frequently observed in a crown-like structure (CLS) sur-
rounding lipid droplet-associated protein (perilipin)-negative 
adipocytes in obese subjects (80, 81, 137). MCP-1 is a well-
known chemokine that attracts macrophages into the adipose 
tissue in obesity. Both MCP-1-deficient mice and MCP-1 
FiGURe 5 | invariant natural killer T (iNKT) cell-mediated regulation of anti-inflammatory response in the adipose tissue. Adipocytes secrete various 
inflammation-inducing factors including FFAs upon excess energy intake, such as HFD. In addition, antigen presentation by CD1d on adipocytes could activate iNKT 
cells, which rapidly secrete great quantities of cytokines, such as IL-4, IL-2, and IL-10. IL-4 produced by iNKT cells induces macrophage polarization into M2 type 
and arginase expression. IL-2 secretion by iNKT cells promotes Treg cell function in the adipose tissue. Activation of anti-inflammatory responses mediated by iNKT 
cells could play a crucial role in the suppression of excessive pro-inflammatory response in the adipose tissue upon HFD.
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receptor CCR2-deficient mice are protected against macrophage 
 accumulation and inflammatory responses in adipose tissues 
and are resistant to DIO-induced insulin resistance (138, 139). 
Adipose tissue macrophages (ATMs) can be divided into M1 
(classically activated) and M2 types (alternatively activated) (2, 
140). The M1 type prominently express inducible nitric oxide 
synthase (iNOS), TNFα, IL-1β, and CD11c on the cell surface, 
whereas M2 macrophages express arginase, IL-10, and Ym-1. It 
has been reported that M1 ATMs are the major contributors to 
adipose tissue inflammation and insulin resistance in obesity. 
Furthermore, mice transplanted with bone marrow depleted 
of CD11c-positive cells show attenuated adipose tissue inflam-
mation and insulin resistance during DIO (141). Although this 
simple dichotomous classification of ATMs has some experi-
mental benefits, it appears that ATMs are composed of diverse 
cell populations not easily classified as M1 or M2.
The polarization of M1 macrophages can be induced by IFNγ 
or lipopolysaccharides (142). In the adipose tissue, IFNγ is pre-
dominantly expressed in T cells, particularly Th1 and CD8 T cells 
(142). The numbers of Th1 and CD8 T cells are elevated in adipose 
tissues of obese subjects (142–144). In mice, CD8 T cell depletion 
reduces M1 macrophage accumulation and TNFα expression in 
the adipose tissue and also improves insulin sensitivity (143). 
Coculture of CD8 T cells and adipose tissue from HFD-fed mice 
increases CD8 T cells proliferation and TNFα expression (143). 
These findings suggest that factors induced in the adipose tissue 
by HFD further activate CD8 T cells. The Th1 cell, a subtype of 
CD4 T cell, is also a major IFNγ-expressing cell that accumulates 
in obesity (144). IFNγ stimulates the expression of chemokines 
and pro-inflammatory cytokines in adipocytes as well as the M1 
polarization of macrophages. Although HFD-fed IFNγ knockout 
mice show no difference in adipose tissue mass, adipose tissue 
inflammation, and glucose tolerance are ameliorated compared 
to wild-type mice (142). These findings suggest that pro-
inflammatory immune cells amplify the inflammatory response 
via cell-to-cell interactions with adipocytes and other immune 
cells, which in turn induces chronic inflammation, adipose tissue 
dysfunction, and insulin resistance.
Anti-inflammatory Cytokine-Producing 
Cells
Other immune cell populations also protect against adipose tissue 
inflammatory responses. For instance, M2 macrophages strongly 
express arginase, which sequesters arginine from iNOS, resulting 
in inhibition of nitric oxide generation and suppression of M1 
macrophage function (2). Moreover, M2 macrophages secrete the 
anti-inflammatory cytokine IL-10 (2). Treatment of adipocytes 
with IL-10 alleviates TNFα-induced insulin resistance (145). 
Activation of STAT6 signaling by Th2-type cytokines, such as 
IL-4, mediates M2 polarization (2). When IL-4 is administered to 
DIO mice, adipose tissue mass and inflammatory responses are 
alleviated, and insulin sensitivity is improved (146). IL-4 is pri-
marily produced by eosinophils in murine adipose tissues (147), 
and compared with wild-type mice, eosinophil-deficient mice 
are more glucose-intolerant upon HFD feeding and show dimin-
ished numbers of M2 ATMs. In contrast, overexpression of IL-5, 
an eosinophil chemoattractant, induces glucose tolerance and 
increases eosinophil numbers in the adipose tissue (147). Thus, it 
has been proposed that eosinophils in the adipose tissue regulate 
insulin sensitivity by mediating M2 macrophage polarization.
Beneficial roles of invariant natural killer T (iNKT) cells 
in adipose tissue inflammation and insulin sensitivity have 
recently been identified, which are associated with secretion of 
anti- inflammatory cytokines, such as IL-4 and IL-10 (Figure 5) 
(148–152). These iNKT cells have unique functional characteristics. 
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For example, iNKT cells recognize the lipid antigen loaded on 
CD1d molecules of antigen-presenting cells, whereas CD4 and 
CD8 T  cells recognize the peptide antigens loaded on MHC 
molecules (153). In addition, iNKT cells can rapidly secrete large 
quantities of cytokines after activation (153). The number of 
iNKT cells in adipose tissues is reduced in obese subjects (149, 
150, 152). In short-term HFD-fed mice, adipose iNKT cell num-
bers are rapidly reduced concomitant with enhanced expression 
of iNKT cell activation markers (152). These results suggest that 
iNKT cells are involved in the early inflammatory response to 
metabolic stress in the adipose tissue. In addition, it has been 
shown that iNKT cell-deficient mice are more susceptible to adi-
pose tissue inflammation and insulin resistance than wild-type 
mice (150, 152). Moreover, when iNKT cells are supplemented by 
adoptive transfer or activated by α-galactosylceramide treatment 
in murine models, body weight gain is reduced; glucose tolerance 
is improved; and anti-inflammatory cytokines, such as IL-4 and 
IL-10, are elevated in DIO (149, 150). Under HFD, the expression 
of the arginase gene is increased in wild type but not in iNKT 
cell-depleted mice, suggesting a crucial role of iNKT cells in M2 
polarization (148). These data suggest that iNKT cells suppress 
adipose tissue inflammation and insulin resistance in DIO mice. 
It was recently suggested that iNKT cells in the adipose tissue 
possess a unique tissue-resident property, unlike iNKT cells in 
other tissues. Moreover, iNKT cells can regulate the functions of 
regulatory T (Treg) cells via IL-2 production as well as those of 
M2 macrophages via IL-10 production in the adipose tissue (154). 
Further, CD1d molecules that present lipid antigens to iNKT cells 
are highly expressed in adipocytes that store large amounts of 
lipid metabolites (151, 152). Despite these recent findings, the 
roles of adipocyte CD1d under physiological and pathological 
conditions and the identity of the endogenous lipid antigens 
exclusively loaded on adipocyte CD1d remain to be elucidated.
Treg cells protect the adipose tissue against severe inflammation 
through cell-to-cell interactions as well as by the secretion of anti-
inflammatory cytokines, such as IL-10 and TGFβ. The number of 
Treg cells is reduced in adipose tissues of obese humans and mice 
models (155). In Treg cell-deficient mice, HFD-induced insulin 
resistance and expression of pro-inflammatory cytokines in the 
adipose tissue are exacerbated (155). Also, it has been reported 
that adipose tissue Treg cells have a 136-fold higher level of IL-10 
transcripts than that in Treg cells in the lymph nodes (155).
Thus, it appears that diverse anti-inflammatory immune cells, 
including eosinophils, M2 macrophages, iNKT cells, and Treg 
cells, can cooperate to resolve inflammatory responses in adipose 
tissues during the early stages of obesity. Taken together, these 
results suggest that chronic excessive energy and an imbalanced 
ratio of pro-inflammatory to anti-inflammatory immune cells 
induce dysregulated immune responses in obese adipose tissues.
Several studies have also shown that the adipose tissue inflam-
matory response differs depending on tissue location (81, 137, 
156–160). It is well known that VAT expansion is a stronger risk 
factor for the development of metabolic syndrome and insulin 
resistance than SAT expansion (70, 161). In addition, obesity-
induced macrophage accumulation is greater in VAT than in 
SAT (137, 156, 158, 159). The mRNA levels of MCP-1, CCR2, 
and macrophage marker genes, such as CD14 and CD163, are 
consistently higher in human VAT than in SAT (156, 159). 
Moreover, IFNγ-secreting CD8 T cells and relative ratios of Th1 
and Th2 cells are higher in VAT than in SAT (162). These differ-
ences in the inflammatory potential between fat depots need to be 
further elucidated to understand the numerical changes and roles 
of each immune cell in obese adipose tissues.
Dynamicity and Reversibility of Adipose 
Tissue immune Cell Balance
In the adipose tissue, the pro-inflammatory response causes 
insulin resistance, whereas the anti-inflammatory response 
preserves insulin sensitivity. The degree of inflammation in the 
adipose tissue is determined by dynamic interactions among 
various immune cells. For example, in mouse models, HFD feed-
ing enhances M1 polarization to accelerate pro-inflammatory 
responses in adipose tissues. However, it is noteworthy that 
absolute number of M2 macrophages in fat tissue weight is 
also increased by HFD at the early stage of obesity (163, 164). 
It appears that immune homeostasis is determined by crosstalk 
between elevated M1 and M2 ATMs despite the change in 
nutritional status (165). On the other hand, each immune cell 
population in the adipose tissue exhibits a unique pattern of 
change under HFD feeding. In mouse models, neutrophils and 
macrophages are rapidly increased, whereas iNKT cells are 
decreased in the adipose tissue within 1 week during HFD (130, 
132, 152). In contrast, the number of Treg cells remains stable for 
10 weeks of HFD feeding (130, 143). These differences suggest 
that various adipose tissue immune cells have distinct roles in 
the adipose tissue immune response and may maintain immune 
balance to prevent uncontrolled pro-inflammatory responses. In 
short-term HFD-fed mice, changes in immune cell populations 
are not sufficient to affect glucose tolerance, possibly because of 
rebalancing of adipose tissue inflammation via crosstalk between 
local immune cell populations (130). However, under chronic 
HFD feeding, cumulative effects induced by long-term changes 
in immune cell populations induce metabolic dysregulation (132, 
152). In other words, when obesity is prolonged, the net balance 
between pro- and anti-inflammation shifts to chronic inflamma-
tion. Without sustainable counteraction by anti-inflammatory 
responses, elevated pro-inflammatory immune cells appear to 
dysregulate adipose tissue functions with the progress of severe 
obesity, thereby disrupting glucose and lipid homeostasis.
Recent studies have revealed that adipose tissue remodeling 
due to inflammation is a reversible phenomenon closely associated 
with insulin sensitivity and adiposity. In both human obesity and 
mouse models, expression levels of pro-inflammatory markers 
and macrophage numbers increase in parallel with insulin resist-
ance. However, after weight loss by calorie restriction, immune 
responses are re-balanced, and insulin sensitivity is restored by the 
reduction of M1 macrophages and induction of M2 macrophages 
(166–168). Furthermore, it has been reported that weight loss 
in obese and diabetic subjects after bariatric surgery results in 
reduced inflammatory gene expression and pro-inflammatory 
immune cell numbers (169–171). Thus, it is likely that rebalanc-
ing of pro- and anti-inflammatory immune cells could be driven 
by external stimuli, such as hormones, cytokines, or chemicals. 
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Activation of M2 ATMs by Th2 cytokines, such as IL-4, attenuates 
the pro-inflammatory response in inflamed adipose tissues and 
ameliorates metabolic complications, including insulin resistance 
(146, 172). These results suggest that immune responses in adi-
pose tissues are reversible and dynamically regulated by factors 
associated with changes in adiposity and immunostimulation, 
which eventually restore systemic insulin sensitivity.
ADiPOSe TiSSUe MACROPHAGeS 
AND TiSSUe ReMODeLiNG
Adipose Tissue Angiogenesis 
and Macrophages
In lean subjects, ATMs contribute to the regulation of adipose tis-
sue function as well as adipose tissue remodeling (173). Multiple 
lines of evidence suggest that ATMs influence angiogenesis in 
adipose tissues (174–178). In mouse models, ATM depletion 
through the use of clodronate liposomes reduces blood vessel 
structures in adipose tissues (178). In addition, macrophages 
recruited into the tip of the gonadal adipose tissue promote angi-
ogenesis during tissue outgrowth (174). In particular, lymphatic 
vessel endothelial receptor 1-positive macrophages secrete tissue 
remodeling factors, such as matrix metalloproteinase (MMP)-7, 
MMP-9, and MMP-12 that stimulate VEGF/VEGFR signaling 
for the formation of new vessels (174). It has been suggested 
that ATMs may be the major cell type that releases MMPs in the 
human adipose tissue (176). In Matrigel, ATMs isolated from the 
human adipose tissue promote the formation of endothelial cell 
tubes by secreting MMPs, such as MMP-9 (176). Extracellular 
matrix (ECM) remodeling, including the degradation of the 
connective tissue and basement membrane proteins, is necessary 
during the early stage of angiogenesis (179, 180). Thus, it has been 
suggested that ATMs contribute to angiogenic remodeling of the 
adipose tissue by modulating ECM.
Remodeling of ECM is also associated with the modulation 
of adipogenesis during adipose tissue expansion. Adipocyte dif-
ferentiation is regulated by the deposition of collagen, a major 
protein component of ECM (181). In addition, it has been 
proposed that adipose tissue fibrosis in obese subjects caused by 
excess deposition of collagen, including type VI, leads to adipose 
tissue inflammation by triggering the infiltration of immune 
cells, such as macrophages, neutrophils, and lymphocytes (87, 
182, 183). Pathological remodeling of ECM may also reduce the 
number of adipose tissue capillaries in obese and insulin-resistant 
subjects (184). Certain subtypes of collagen appear crucial for 
adipose tissue fibrosis-mediated inflammation and metabolic 
dysfunction in obesity (182, 183). Deletion of collagen VI in 
obese mice improves metabolic parameters and inflammatory 
profiles even though overall collagen content of the adipose tis-
sue is not altered (182). However, it remains to be determined 
whether MMPs secreted from ATMs prevent collagen deposition 
linked to adipose tissue fibrosis.
Accumulation of ATMs is a key factor aggravating inflam-
matory responses in adipose tissues (2–4). However, recruited 
ATMs in obese adipose tissues may also play a protective 
role by enhancing angiogenesis in response to local hypoxia. 
Hypoxia is one of the most potent microenvironmental  factors 
for macrophage recruitment into adipose tissues (185), and 
recruited macrophages are the predominant producers of 
pro-angiogenic factors in response to hypoxia (186). In mouse 
obese adipose tissues, ATM depletion decreases the expression 
level of platelet-derived growth factor (PDGF), an angiogenic 
factor that mediates endothelial cell tube formation and capil-
lary maturation by pericyte recruitment (177). These results 
indicate that ATMs could be an important source of PDGF 
for angiogenesis. Furthermore, pro-inflammatory cytokines 
released from ATMs, such as TNFα, could act as angiogenic 
factors (187–189). Therefore, it has been speculated that ATMs 
may counteract hypoxia by promoting angiogenesis through 
production of angiogenic factors. However, recent elucidation 
of ATM-mediated angiogenesis in the obese adipose tissue still 
needs to be confirmed in vivo.
Clearance of Dead Adipocytes 
and Macrophages
Another potential physiological role of ATMs in obesity is the 
clearance of dead or damaged adipocytes and fragmented cellular 
contents. In DIO mice, perilipin-negative adipocytes show fea-
tures of necrosis-like death, such as plasma membrane rupture, 
dilated endoplasmic reticulum, and cell debris (80, 81). Most of 
the recruited ATMs in obese adipose tissues are present near 
perilipin-negative adipocytes, forming CLSs (80, 81). These CLS 
macrophages are multinucleated giant cells that surround residual 
adipocyte lipids, implying that CLS macrophages scavenge free 
lipids released from dead adipocytes to the interstitium (80). It 
was recently shown that depletion of mannose-binding lectin, 
which stimulates the phagocytic capacity of ATM, increases the 
numbers of CLSs in the adipose tissue of DIO mice, and decreases 
dead adipocyte clearance (190). Thus, it is likely that macrophage 
recruitment into the obese adipose tissue is involved in the clear-
ance of dead adipocytes via phagocytosis. Furthermore, it has been 
suggested that ATMs could mediate the removal of extracellular 
lipids from adipose tissues (191). In both fasted and HFD-fed 
mice, ATMs absorb FFAs released from the adipocytes. This phe-
nomenon could contribute to the prevention of lipotoxicity by 
buffering local extracellular FFA elevations in the adipose tissue. 
In obesity, however, lipid-loaded ATMs resembling foam cells 
have been suggested to have pro-inflammatory characteristics 
(192, 193) that contribute to insulin resistance. In both mice with 
adipocyte-targeted activation of caspase-8 and fat-transplanted 
mice, adipocyte death facilitates the recruitment of M1 and M2 
macrophages (194, 195). It is possible that M1 macrophages 
phagocytize dead adipocytes, whereas M2 macrophages recon-
struct ECM and resolve the activation of M1 macrophages after 
removal of dead adipocytes. These complementary functions of 
M1 and M2 macrophages may minimize tissue damage through 
tight regulation of phagocytosis and tissue repair. However, in 
obesity, the balance between M1 and M2 ATMs appears to be 
shifted by a greater increase in M1 macrophage number (2–4). 
Enhanced M1 polarization of ATMs in obese adipose tissues 
may interrupt the normal process of dead cell clearance, whereas 
further stimulating a pro-inflammatory response.
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Adaptive Thermogenesis and Adipose 
Tissue Macrophages
In response to cold exposure, β-adrenergic signaling modulates 
adaptive thermogenesis in BAT and SAT by promoting uncoupled 
respiration and thermogenic gene expression (40). Also, chronic 
cold exposure leads to the remodeling of BAT and SAT, result-
ing in a dramatic increase in the metabolic rate, mitochondrial 
biogenesis, and fatty acid oxidation (40). Emerging evidence sug-
gests that M2 ATMs mediate thermogenic adipose tissue remod-
eling in response to cold exposure (196–198). Chawla’s group 
proposed that M2 ATMs induce thermogenic tissue remodeling 
by amplifying cold-induced β-adrenergic signaling via local 
catecholamine production (196, 198). In accordance with this 
notion, ATM depletion suppresses the cold-induced increase in 
thermogenic gene expression, lipolysis, and energy expenditure. 
In addition, blockage of M2 polarization by inhibition of IL-4 
signaling diminishes adaptive thermogenesis and attenuates the 
generation of UCP-1-positive beige adipocytes in SAT. It has 
also been suggested that M2 ATMs promote the accumulation 
of PDGFRα-positive progenitor cells through osteopontin secre-
tion and downstream β-adrenergic signaling (197). Recruited 
PDGFRα-positive progenitor cells can differentiate into UCP-1-
positive adipocytes. Thus, it is likely that the interaction between 
M2 ATMs and PDGFRα-positive progenitor cells mediates the 
de novo differentiation of beige adipocytes in SAT during cold 
exposure. Together, these results indicate that ATM-associated 
adipose tissue remodeling is intimately involved in the modula-
tion of adipose tissue function as well as adipose tissue growth 
and expansion in changing environments.
CONCLUSiON
We have focused on the physiological and pathological roles of 
the adipose tissue and its remodeling in regulating whole-body 
energy metabolism by sensing the nutritional status and crosstalk 
between adipocytes and stromal vascular cells. During adipose 
tissue expansion, numerous cellular responses are dynamically 
altered. Modulation of ECM remodeling and angiogenesis may 
promote differentiation of de novo adipocytes, preventing the 
formation of hypertrophic adipocytes by providing additional 
capacity to store extra lipids. Recruited ATMs probably act to 
remove dead adipocytes and repair damaged adipose tissue for 
healthy adipose tissue remodeling. Adipose tissue remodeling is 
modulated by the inflammatory responses of multiple immune 
cell types, including macrophages and lymphocytes. However, in 
obesity, chronic excessive energy storage in the adipose tissue ini-
tiates pathological remodeling, which triggers pro-inflammatory 
responses of immune cells. Furthermore, tissue remodeling, 
including angiogenesis and tissue repair for healthy expansion 
of the adipose tissue, is hindered by inflammatory and metabolic 
stress. Thus, resolving uncontrolled pro-inflammatory responses 
during adipose tissue remodeling is important for maintaining a 
metabolically healthy status. Adipose tissue remodeling is a com-
plex but well-orchestrated mechanism modulated by multiple 
adipose tissue cell types that allow adaptation to external environ-
mental changes. A deeper mechanistic understanding of adipose 
tissue remodeling could facilitate the development of therapeutic 
approaches against obesity-induced metabolic diseases.
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